?? ?Methypregnone (Medroxyprogesterone Acetate) | High-Purity Hormone API for Contraceptives & Therapeutics?

?? ?Product Overview?

Methypregnone, a synthetic progestin, is widely used for ?long-acting contraception? and ?hormone replacement therapy (HRT)?. It regulates endometrial growth and suppresses ovulation via progesterone receptor activation?. Key applications include:

• ?Contraceptive formulations? (injectables/oral)

• ?HRT?for menopause management

• ?Gynecological disorders? (endometriosis, amenorrhea)

? ?Key Advantages?

?? ?Applications?

1. 1?.Women’s Health?

• ?Monthly contraceptive injections? (e.g., Depo-Prova? generics)?

• ?HRT? to reduce osteoporosis risk in postmenopausal patients?

2. 2?.Veterinary Medicine? 

• Estrous cycle regulation in livestock?

?? ?Quality & Compliance?

• Manufactured in ?GMP-certified facilities? (ISO 9001:2025)?

• Meets ?USP/EP monographs? for impurities (<0.5% total)?

• Stability tested under ICH Q1A guidelines (24-month shelf life)?

?? ?Market Trends?

The global hormonal contraceptive market is projected to reach ?$23.8B by 2027? (CAGR 3.9%), driven by rising demand for long-acting reversible contraceptives?. Over 65% of HRT APIs are supplied by GMP-certified manufacturers?.